National Institutes of Health: all 11,571 studies

Page 114 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisCompletedNCT00000595Phase 2
• NHLBI Type II Coronary Intervention StudyCompletedNCT00000594Phase 3
• Viral Activation Transfusion Study (VATS)CompletedNCT00000593Not applicable
• T-Cell Depletion in Unrelated Donor Marrow TransplantationCompletedNCT00000591Phase 3
• Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)CompletedNCT00000590Phase 3
• Trial to Reduce Alloimmunization to Platelets (TRAP)CompletedNCT00000589Phase 3
• Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)CompletedNCT00000586Phase 3
• Penicillin Prophylaxis in Sickle Cell Disease (PROPS)CompletedNCT00000585Phase 3
• Transfusion-Transmitted Cytomegalovirus Prevention in NeonatesCompletedNCT00000584Phase 3
• Hepatitis B Vaccine Clinical TrialCompletedNCT00000583Phase 3
• Cooperative Study of Factor VIII InhibitorsCompletedNCT00000582Phase 3
• Granulocyte Transfusion StudyCompletedNCT00000581Phase 3
• Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3
• Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)CompletedNCT00000579Phase 3
• NHLBI/NICHD Collaborative Studies of Asthma in PregnancyCompletedNCT00000578Phase 3
• Inhaled Beclomethasone to Prevent Chronic Lung DiseaseCompletedNCT00000576Phase 3
• Emphysema: Physiologic Effects of Nutritional SupportCompletedNCT00000573Phase 2
• Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter TrialCompletedNCT00000570Phase 3
• Lung Health Study (LHS) I and IIICompletedNCT00000568Phase 3
• High Frequency Ventilation in Premature Infants (HIFI)CompletedNCT00000567Phase 3
• Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)CompletedNCT00000566Phase 3
• Clinical Study of Intermittent Positive Pressure Breathing (IPPB)CompletedNCT00000565Phase 3
• Nocturnal Oxygen TherapyCompletedNCT00000564Phase 3
• Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid AdministrationCompletedNCT00000563Phase 3
• Extracorporeal Support for Respiratory Insufficiency (ECMO)CompletedNCT00000562Phase 3
• Beta-Blocker Evaluation in Survival Trial (BEST)CompletedNCT00000560Phase 3
• Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)CompletedNCT00000559Phase 3
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)CompletedNCT00000558Phase 3
• Enhancing Recovery in Coronary Heart Disease (ENRICHD) PatientsCompletedNCT00000557Phase 3
• Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)CompletedNCT00000556Phase 3
• Women's Angiographic Vitamin and Estrogen Trial (WAVE)CompletedNCT00000555Phase 3
• Activity Counseling Trial (ACT)CompletedNCT00000551Phase 3
• Estrogen Replacement and Atherosclerosis (ERA) in Older WomenCompletedNCT00000549Phase 3
• Enalapril After Anthracycline CardiotoxicityCompletedNCT00000547Phase 3
• Stress Reduction and Atherosclerotic CVD in BlacksCompletedNCT00000546Phase 3
• PATHWAYS--FULL SCALE STUDYCompletedNCT00000545Phase 2
• Dietary Approaches to Stop Hypertension (DASH)CompletedNCT00000544Phase 3
• Oral Calcium in Pregnant Women With HypertensionCompletedNCT00000543Phase 2
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)CompletedNCT00000542Phase 3
• Coronary Artery Bypass Graft (CABG) Patch TrialCompletedNCT00000540Phase 3
• Arterial Disease Multifactorial Intervention Trial (ADMIT)CompletedNCT00000539Phase 3
• Stress Reduction & CVD Morbidity and Mortality in BlacksCompletedNCT00000537Phase 2
• Trial of Nonpharmacologic Interventions in Elderly (TONE)CompletedNCT00000535Phase 3
• Calcium for Pre-Eclampsia Prevention (CPEP)CompletedNCT00000534Phase 3
• Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and MenopauseCompletedNCT00000532Phase 3
• Antiarrhythmics Versus Implantable Defibrillators (AVID)CompletedNCT00000531Phase 3
• Raynaud's Treatment Study (RTS)CompletedNCT00000530Phase 3
• Trials of Hypertension Prevention (TOHP)CompletedNCT00000528Phase 3
• Cardiac Arrhythmia Suppression Trial (CAST)CompletedNCT00000526Phase 3
• Optimal Exercise Regimens for Persons at Increased RiskCompletedNCT00000523Phase 2
• Prevention of Coronary Aneurysms in Kawasaki SyndromeCompletedNCT00000520Phase 2
• Studies of Left Ventricular Dysfunction (SOLVD)CompletedNCT00000516Phase 3
• Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)CompletedNCT00000515Phase 3
• Systolic Hypertension in the Elderly Program (SHEP)CompletedNCT00000514Phase 3
• Trial of Antihypertensive Intervention ManagementCompletedNCT00000513Phase 3
• Platelet-Inhibitor Drug Trial in Coronary AngioplastyCompletedNCT00000510Phase 3
• Cardiovascular System in Obesity: Effect of TreatmentCompletedNCT00000506Phase 2
• Thrombolysis in Myocardial Infarction (TIMI)CompletedNCT00000505Phase 3
• Cardiac Arrhythmia Pilot Study (CAPS)CompletedNCT00000504Phase 2
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary ArteriesCompletedNCT00000503Phase 3
• Evaluation of SC-V Versus Conventional CPRCompletedNCT00000502Phase 3
• Hypertension Prevention Trial (HPT) Feasibility StudyCompletedNCT00000501Phase 2
• Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)CompletedNCT00000499Phase 2
• Control of Hypertension by Non-Pharmacologic MeansCompletedNCT00000498Phase 3
• Platelet Drug Trial in Coronary Disease ProgressionCompletedNCT00000496Phase 3
• Management of Patent Ductus in Premature InfantsCompletedNCT00000494Phase 3
• Multicenter Investigation of Limitation of Infarct Size (MILIS)CompletedNCT00000493Phase 3
• Beta-Blocker Heart Attack Trial (BHAT)CompletedNCT00000492Phase 3
• Aspirin-Myocardial Infarction Study (AMIS)CompletedNCT00000491Phase 3
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)CompletedNCT00000488Phase 3
• Unstable Angina Pectoris TrialCompletedNCT00000486Phase 3
• Hypertension Detection and Follow-up Program (HDFP)CompletedNCT00000485Phase 3
• Treatment of HypertensionCompletedNCT00000484Phase 3
• Coronary Drug Project Mortality SurveillanceCompletedNCT00000483Not applicable
• Coronary Drug ProjectCompletedNCT00000482Phase 3
• Women's Health Trial: Feasibility Study in Minority PopulationsCompletedNCT00000481Phase 3
• Multicenter Unsustained Tachycardia Trial (MUSTT)CompletedNCT00000480Phase 3
• Asymptomatic Cardiac Ischemia Pilot (ACIP) StudyCompletedNCT00000478Phase 3
• Cholesterol Reduction in Seniors Program (CRISP)CompletedNCT00000477Phase 2
• Digitalis Investigation Group (DIG)CompletedNCT00000476Phase 3
• Prevention of Early Readmission in Elderly Congestive Heart Failure PatientsCompletedNCT00000475Phase 2
• Prevention and Treatment of Hypertension Study (PATHS)CompletedNCT00000474Phase 3
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?CompletedNCT00000473Phase 3
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)CompletedNCT00000472Phase 3
• Lifestyle Heart TrialCompletedNCT00000471Phase 2
• Asymptomatic Carotid Artery Plaque Study (ACAPS)CompletedNCT00000469Phase 2
• Child and Adolescent Trial for Cardiovascular Health (CATCH)CompletedNCT00000467Phase 3
• Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3
• Emory Angioplasty Versus Surgery Trial (EAST)CompletedNCT00000465Phase 3
• Post Coronary Artery Bypass Graft (CABG) StudyCompletedNCT00000463Phase 3
• Bypass Angioplasty Revascularization Investigation (BARI)CompletedNCT00000462Phase 3
• Harvard Atherosclerosis Reversibility Project (HARP)CompletedNCT00000461Phase 2
• Dietary Intervention Study in Children (DISC)CompletedNCT00000459Phase 3
• Sertraline and Cognitive Therapy in Depressed AlcoholicsCompletedNCT00000458Phase 2
• Naltrexone Treatment of Alcohol DependenceCompletedNCT00000452Phase 4
• Behavior and Naltrexone Treatment for AlcoholicsCompletedNCT00000449Phase 4
• Drug Treatment for Alcoholics With Post-Traumatic Stress DisorderCompletedNCT00000446Phase 2
• Use of Naltrexone in a Clinical SettingCompletedNCT00000445Phase 4
• Ondansetron Treatment for AlcoholismCompletedNCT00000443Phase 2
• Drug Therapy for Alcohol DetoxificationCompletedNCT00000441Phase 4

← National Institutes of Health overview and focus areas